Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company’s cost-cutting efforts following waning post-pandemic demand for its COVID-19 vaccine.
Moderna Beats Wall Street Estimates For First-Quarter Profit And Sales
About the Author: ryounglao
Leave A Comment